Burning Rock Biotech Stock (NASDAQ: BNR) stock price, news, charts, stock research, profile.
Open | $0.755 |
Close | $0.748 |
Volume / Avg. | 345.295K / 46.896K |
Day Range | 0.740 - 0.800 |
52 Wk Range | 0.572 - 3.250 |
Market Cap | $82.489M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 0 |
Short Interest | 0.46% |
Days to Cover | 12.93 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Burning Rock Biotech (NASDAQ: BNR) through any online brokerage.
Other companies in Burning Rock Biotech’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Connect Biopharma Hldgs (NASDAQ:CNTB), CARISMA Therapeutics (NASDAQ:CARM), Barinthus Biotherapeutics (NASDAQ:BRNS) and Gritstone Bio (NASDAQ:GRTS).
The latest price target for Burning Rock Biotech (NASDAQ: BNR) was reported by CICC on Wednesday, July 14, 2021. The analyst firm set a price target for 39.94 expecting BNR to rise to within 12 months (a possible 4871.37% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Burning Rock Biotech (NASDAQ: BNR) is $0.8034 last updated April 29, 2024 at 7:58 PM EDT.
There are no upcoming dividends for Burning Rock Biotech.
Burning Rock Biotech’s Q1 earnings are confirmed for Tuesday, May 28, 2024.
There is no upcoming split for Burning Rock Biotech.
Burning Rock Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.